Tandem Diabetes Care Inc : Leerink Partners Cuts Target Price to $58 From $59
Tandem Diabetes Care Inc:Leerink Partners 將目標價從$59降至$58
Tandem Diabetes Care Inc : Leerink Partners Cuts Target Price to $58 From $59
Tandem Diabetes Care Inc:Leerink Partners 將目標價從$59降至$58
譯文內容由第三人軟體翻譯。
使用瀏覽器的分享功能,分享給你的好友吧